chrisvoncsefalvay/vaers-outcomes huggingface dataset:
severe mouth dryness that pushed to be drinking water; Injection site pain; somnolence; feeling tired; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of unspecified age received bnt162b2 (BNT162B2, Batch/Lot Number: EM9809) via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 1,SINGLE for an unspecified indication at Health Clinic . The patient medical history was not reported. Concomitant medication(s) included metformin (1000), lisinopril (20mg) and atorvastatin (40) taken for an unspecified indication, start and stop date were not reported. The patient had no Covid prior vaccination.The patient had not covid tested post vaccination. On 09Feb2021 at 04:45,The patient experienced severe mouth dryness that pushed to be drinking water, injection site pain, somnolence and feeling tired. Treatment reported as no. The outcome of the events was recovering on an unspecified date.    Follow-up attempts completed. No further information expected.
This serious case was received from a health professional on 01 December 2008. A four year-old male patient, with no known allergies and no medical conditions, received the following vaccines on 26 November 2008: a fifth right thigh injection of DAPTACEL (lot number C3000AA); a fourth left thigh injection of IPOL (lot number A1060-2); a left thigh injection of MMR II (Merck, lot number 1011X); and a left thigh injection of VARIVAX (Merck, lot number 0975X). Immediately after vaccination, the patient experienced wheezing, swelling of the eyes, sneezing, a rash, and "itchy feet". He was treated with nebulizer treatments and prednisone, and then sent home. The outcome was unknown. The reporter in this case also reported a similar event in another 4 year-old patient; this event was captured in case number 2008-03837. Documents held by sender: None.
Patient came into the office with parent for 2nd dose of Peds Pfizer Vaccine, CVPP and I pulled the wrong vaccine, CVPO and administered to patient in the right deltoid which is the Peds Pfizer Bivalent dose; we do not have in stock; I immediately reported to my Nurse Manager, spoke with parent about vaccine error; obtained V/S normal (P94, R18, BP 112/78; T98, O2 98%); monitored patient for an hour; no distress noted; no S/S of any adverse effects; no swelling noted; no SOB; denies pain at site at this time; patient is alert/oriented; smiling, talking with her parents, and playing on her mobile device; parent verbalized understanding; I advised parent/patient someone will be in touch with her within 24 hours for follow up with the child
Client received flu vaccine at approx. 08:40 AM.She called health dept. at approx 14:30 stating she was having a reaction to flu shot.  Having difficulty breathing, covered with whelps and swelling behind her ears.  States she has asthma.  Instructed to come to HD ASAp or go directly to ER if necessary.  1500 we called client and she stated she was on her way.  1515 client here and found to have large, red, raised whelps covering most of face, neck, and torso.  Did not complain of itching but a burning sensation from whelps.  Has asthma, on PRN meds.  No edema noted behind ears, no frank respiratory distress, naturally anxious.  Referred to local ED.  We did not have contact with client on Friday but it was reported to us that she was at the football game and having no problems.  Follow up on Monday  (11-05-07) found her to be doing well.  She was given meds at ER but cannot remember the name of them.  Whelps have completely subsided with no apparent residual.  She said ED physician said: "it could be a reaction to the flu vaccine, I am not sure."  We talked with her on Thursday (11-08-07) and she continues to do well.
I showed symptoms of COVID on April 3, 2022. (Chills, cough, runny nose, ache, fatigue.) I called Dr.  on April 4. He recommended I take a self COVID test. I did and the result was positive. He prescribed a round of anti virals. I took them for five days and tested negative for COVID after.
pt received 2nd dose of Moderna bivalent booser 2 days after 1 st dose of bivalent booster
Patient vaccinated multiple times with HPV vaccine, had a total of 6 vaccines; Unsure which HPV vaccine the first 3 doses series was; This spontaneous report was received from a Pediatrician concerning a 18-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.      On unknown dates, the patient was vaccinated with three doses of an unspecified HPV (human papillomavirus) vaccine for prophylaxis (dose, strength, route of administration, lot number and expiration dates were not reported). After that, on unspecified dates, the patient received a second three dose series of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) for prophylaxis (dose, strength, route of administration, lot number and expiration dates were not reported).  At the reporting time, the patient had received a total of 6 vaccinations. No PQC (product quality complaint) was reported.
Patient presented w/complaint of myalgia, subjective fevers at home. Mildly tachycardic. Tachycardia resolved with fluid bolus. Patient G/POAO at 40 wod. Tx: 1) Proceed with misoprostol induction of labor. 2) Start TAMIFLU. 3) IV fluids. 4) Anticipate SVD. Vaccine failure.
I am reporting that the Moderna vaccination was given inadvertently before the minimum age 18 requirement.
HPV # 2 - pt had at 8:30/AM - went to school - at 11 AM c/o being lightheaded and nausea. Mother states "had similar reaction" with HPV #1, but did not report. Increased fluids - pt had no further problems.
small red dots and sever itch starting on chest and shoulders extending down arms and side to include hips and buttock.  stopped all antibiotics and started predesone pack
Pain, swelling, itching at injection site within 24 hrs of injection. 4cm X 4 cm area of redness and edema noted RD.
On 9/14/22 I was in the bathroom washing my face and suddenly came up behind me it felt like someone put a knife in my back and I couldn't take a deep breath because of the pain and it was a sharp pain when I inhaled and I was like what the heck and I went into my bedroom and sat in the chair and I was thinking I was having a heart attack so I took an aspirin and it didn't pass and I started getting cold and felt foggy and my daughter in law took me to the emergency room. All my test were normal and they prescribed me NORVASC due to my hypertension and I have an appointment with my primary care doctor. They thought it might of have been a muscle pull but I know what that feels like and it was not it. I don't know if the shot caused it but it was weird. I feel more tired than usual, generally more fatigued.
fever persists; dry cough; runny nose; diagnosed COVID-19 positive on Oct 30; diagnosed COVID-19 positive on Oct 30; This is a spontaneous report from a contactable consumer or other non-health care professional. An 87-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and Expiration Date: was not reported), via an unspecified route of administration, administered in left arm, on 24Mar2021 at 15:00 (age at vaccination: 86-year-old), as dose 2, single for COVID-19 immunization in Pharmacy or Drug Store and the patient received first dose of bnt162b2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and Expiration Date: was not reported), via an unspecified route of administration, administered in left arm, on 03Mar2021 at 15:00 (age at vaccination: 86-year-old), as dose 1, single for COVID-19 immunization. Medical history included blood cholesterol abnormal and hypertension from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient did not receive any other vaccines in four weeks. Prior to vaccination, the patient was not infected to COVID-19. The patient had no allergies. The patient was exposed on 25Oct2021 (with mask) and on 26Oct2021 (without mask) to a same person who was tested positive for COVID-19 but no symptoms and informed patient on 31Oct2021. On 28Oct2021, the patient experienced dry cough, runny nose. On 29Oct2021, the patient experienced fever of 101 degrees Fahrenheit. On 30Oct2021, the fever persists, the patient went to urgent care and tested positive. The adverse event resulted in emergency room and physician office visit. The patient underwent lab tests and procedures which included body temperature: 101 Fahrenheit on 29Oct2021, SARS-CoV-2 test (Nasal Swab): positive on 30Oct2021. As a therapeutic measure, the patient received treatment with REGEN monoclonal antibody IV infusion, azithromycin, Vitamin D3, Zinc, Calcium, melatonin, green tea. The outcome of the events was resolving.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Patient is a 37y.o. y.o. female who presents to the ED on 11/23/21 for evaluation of possible LUE DVT. Patient was dx with pneumonia on Friday, confirmed COVID positive yesterday, and was sent in by her PCP today for concern of DVT. Pt has PICC line present to RUE and states that she has a hx of DVT around it, and is concerned she has another one. Reports hx of clotting disorders for which she is taking blood thinners. Pt has been taking doxycycline and prednisone for her pneumonia. There are no other complaints or modifying factors at this time.   Review of Systems  Constitutional: Negative for chills and fever.  Respiratory: Positive for cough and shortness of breath. Negative for wheezing.   Cardiovascular: Negative for chest pain and palpitations.  Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting.  Genitourinary: Negative for dysuria, frequency and urgency.  Musculoskeletal: Negative for back pain and neck pain.  Skin: Negative for rash.  Neurological: Negative for headaches.  Psychiatric/Behavioral: Negative for suicidal ideas.
Swollen left leg and left foot, redness, bright red rash on left cheek, low grade fever, fussiness, pain in left leg/foot, refusal to use left leg.
This spontaneous report as received from an unknown age reporting on herself a Licensed Practical Nurse. On an unknown date, the reporter stated that because there was excessive pressure coming from the product vial of ZOSTAVAX (dose, lot#, expiration date and route not reported), it shot out onto her skin on her face and neck. The reporter was able to wipe it off and reported no adverse experience. PQC reported because of the excessive pressure in the vial. It was unknown if the patient sought medical attention. Additional information has been requested.
Progressive redness and swelling to 10-12cm at site of injection over 3 days. Resolved after 2 days of treatment with Zyrtec or Ibuprofen. It may have been a dermal injection.
pt recv vax 16OCT97 & 18OCT arm hurt, visited hosp ER 20OCT97;dx tendonitis lt arm told to take pain killers & put arm in sling;23OCT97 arm still sore, radiated down back of hand & up over shoulder;told to see own MD;
This spontaneous report was received from a registered nurse, and refers to a 34 year old female patient. No information about the patient's medical history, concurrent conditions and drug reactions or allergies was provided. The patient had no concomitant medications. The patient historical drugs included TDAP for prophylaxis on 08-JAN-2018. On 12-FEB-2018, the patient was vaccinated with improperly stored doses of Oka/Merck VARIVAX dose 1, subcutaneous in the right arm, (Lot # M030138 with an expiration date in 15-JUN-2018), and (wistar ra 27-3) M-M-R II dose 2, subcutaneous in the left arm, therapy type (rHA), (Lot # M028130 with an expiration date in 03-JUN-2018), for prophylaxis, that underwent multiples temperatures excursions from -14 degrees Celsius to -10 degrees Celsius during a maximum time frame of 7 hours, Digital data logger was involved. Nevertheless, it was reported that both vaccines were reconstituted with properly stored sterile diluent (manufacturer unknown). No adverse effects were reported and no product quality complaint was involved.
This spontaneous report was received from a Licensed Practical Nurse and refers to a 18-year-old patient. No information regarding the patient's medical history and concurrent conditions was provided. On an unknown date, the patient was vaccinated with an improperly stored dose of GARDASIL 9 injection (dose and route of administration were not reported) lot # N013276 with expiration date on 21-JAN-2020. The vaccine underwent a temperature excursion of 0.1 degrees Celsius for 6 hours. Digital data logger was involved in the recording of the excursion. Unspecified previous excursions were reported. No adverse events were reported. This is one of several reports received from the same source. Sender's Comments: US-009507513-1712USA001308.
March 15 had mild scratchy throat and a little tired. The next morning was very fatigued, low grade temperature, congestion, cough, sore throat. Tested positive on 03/17. Telehealth visit and was told to rest and hydrate. Symptoms resolved in 14 days.
patient may have potentially only received 0.25ml of the Moderna Covid-19 bivalent vaccine dose; No Adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (patient may have potentially only received 0.25ml of the Moderna Covid-19 bivalent vaccine dose) and NO ADVERSE EVENT (No Adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (patient may have potentially only received 0.25ml of the Moderna Covid-19 bivalent vaccine dose) and NO ADVERSE EVENT (No Adverse event). At the time of the report, UNDERDOSE (patient may have potentially only received 0.25ml of the Moderna Covid-19 bivalent vaccine dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient may have potentially only received 0.25ml of the Moderna Covid-19 bivalent vaccine dose).    No concomitant medication was reported. It was reported that a patient may have potentially only received 0.25ml of the Moderna Covid-19 bivalent vaccine dose. INo other events are known of. No treatment medication was reported.
COVID-19 INFECTION (COVID-19, COVID-19) This spontaneous report received from a consumer via a company representative and concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. We are unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient developed covid-10 infection. On an unspecified date, the patient died from covid-19. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).
Immediately after receiving FLUMIST child reports nasal burning. I hour later dizziness and sore throat. 4 hours later he had a fever of 102 degrees and was given Ibuprofen. Fever lasted 24-36 hours.
Received Moderna booster on 12/10/21. With prior two doses I didn't experience any hives or similar issues; I did have flu-like symptoms for 1-2 days post vaccine with shots #1 and #2. About 10 days after getting the booster I woke to intense itchiness on the scalp, hairline, and neck. It eventually resolved when I took an Allegra. Since that day, every morning (and some evenings) I experience severe itching. It always occurs on the scalp, and then on other random areas as well. There is no discernable trigger for why a specific area begins to itch; sometimes it seems to be related to contact from a piece of clothing, and sometimes there's no clear trigger. The itching includes redness and raised hives. It always resolves or becomes tolerable upon taking an Allegra, but may return that evening as the medication wears off.
This spontaneous report as received from a male patient of unknown age who was reporting on himself. In August 2017 (reported as "last week"), the patient was vaccinated with ZOSTAVAX for prophylaxis. In August 2017, the patient experienced expired product administered. No adverse symptoms reported. The outcome of expired product administered was unknown. Additional information has been requested.
felt rapid heart rate, felt had a fever, faint, felt bad x 45min;then resolved over next 15min;p/1hr period, felt nl;
This spontaneous report was received from a physician and from a support services director via company representatives and refers to a patient of an unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 14-DEC-2015, the patient was vaccinated with a dose of an improperly stored GARDASIL 9 (strength: 0.5 ml) lot # L014198 and expiration date: 05-SEP-2017 (dose, anatomical location and route of administration were not reported). No adverse effects were reported. The dose of the vaccine was exposed to different temperature excursions (date unspecified): lasting for 320, 88, 232, and 40 hours, with the lowest recorded temperature of 29, 30, 33, and 34 degrees Fahrenheit (-1.66, -1.11, 0.55, and 1.11 degrees Celsius) respectively; and lasting for 64 hours, with the highest recorded temperature of 48 degrees Fahrenheit (8.88 degrees Celsius). The vaccine was stored in a refrigerator. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received second dose pfizer when he should have received second dose Moderna.  Patient notified of vaccine administration error.
The booster dose has not been very good to me.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (The booster dose has not been very good to me.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (The booster dose has not been very good to me.). At the time of the report, VACCINATION COMPLICATION (The booster dose has not been very good to me.) outcome was unknown.            No concomitant medication was reported.  No treatment medication use was reported.
Was fine after receiving shot. Woke up at 4: 00 a.m. next morning with 101.5 fever. Took Tylenol but would not go down. Called primary doctor. Told me to take ADVIL. Still would not go down. After hours and very weak, called 911 and ambulance too me to the hospital. Arrived and they too vitals. Still high fever. Blood work showed high white blond count. stayed at hospital until late at night. Fever went down. Told me some people have thee type of issues with Moderna. Checked brochure Moderna provided  says fever but not High fever. Doctor dismissed me from ER and told me to rest the next two days. I had Covid in October 2020. They wnet ahead and did another test. Waiting on results
severe sudden onset hearing loss/ another person who is experiencing the same; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the second of two reports.      A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, it was reported that the patient experienced severe sudden onset hearing loss/ another person who is experiencing the same. The event was assessed as serious (medically significant). The outcome of the event was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021314158 same reporter/similar AE/drug and different patient.
Bled  at time of injection at point of needle insertion, sore upper arm/shoulder immediately following vaccination,  discomfort/pain progressed for days in upper arm, movement of arm became limited for over two weeks, bed rest for six days treating with ibuprofen to treat pain and possible inflammation, bruising at injection site still visible 18 days post injection, mobility and discomfort improving.
Febrile 102, chills, lethargy, fever was 100 the second day and 99.5 on day three. Lethargy improved when fever decreased.
Shortness of breath. Asthmatic effects,It got really bad , doctor prescribed inhaler medication.
Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included SERTRALINE for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt had red macular rash to face, arms, and chest at least 30 minutes after vaccination. symptoms improved after decadron IM and symptoms began to resolve within one hour
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms, fever, muscle pain, joint pain, distress gastrointestinal, injection site pain, injection site edema, injection site erythema and injection site warmth. On an unknown date, the outcome of the influenza-like symptoms, fever, muscle pain, joint pain, distress gastrointestinal, injection site pain, injection site edema, injection site erythema and injection site warmth were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, fever, muscle pain, joint pain, distress gastrointestinal, injection site pain, injection site edema, injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were reported as follows: The reporter said he already reported this adverse event to the company in the past. He could not remember the details anymore. In 2018, the patient vaccinated with a dose of SHINGRIX. It took him about 2 weeks to recovered from the symptoms. The symptoms were intestinal distress, red spot that was tender to the touch at the injection site, elevated temperature at the injection site. The reporter said that the symptoms went away after about 2 weeks.